We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Mixed revenue trends emerge from the latest batch of quarterly updates Proteomics plans to launch i...
Read ArticleTony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998....
Read ArticleHealth Check is renowned biotech journo Tim Boreham’s daily wrap covering morning movers and shakers...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX falls on Wednesday with banks dragging down market Lithium stocks surge on CATL suspension r...
Read ArticleThe ASX200 has been down 0.3% at 7,988 points in early afternoon trade. Gold prices have climbed...
Read ArticleProteomics International Laboratories Ltd (ASX:PIQ) has seen its share price plunge more than 20% on...
Read ArticleProteomics and US partner Sonic Healthcare say ‘I don’t’ and go their separate ways The company hop...
Read ArticleProteomics International Laboratories’ “PromarkerD” device that uses a simple finger-prick blood tes...
Read ArticleProteomics International Laboratories (ASX: PIQ) has obtained what it describes as “groundbreaking”...
Read ArticleProteomics International Laboratories has sealed a new deal with medical diagnostics company Eurobio...
Read ArticleProteomics International Laboratories is escalating its expansion into the European market after app...
Read ArticlePredictive diagnostics medical company Proteomics International Laboratories (ASX: PIQ), has engaged...
Read ArticleHaving served as Proteomics chief since he co-founded the company in 2001, Dr Richard Lipscombe is u...
Read ArticleResearch conducted by Proteomics International Laboratories and Curtin University has made a crucial...
Read ArticlePredictive diagnostics specialist Proteomics International Laboratories (ASX: PIQ) has signed an agr...
Read ArticleMarkets are less volatile as traders anticipate easing of rates But the path in Australia may no...
Read ArticleThe ASX200 has closed the trading day just above even. The sectors were split, with Financials le...
Read ArticleWorld Overnight SPI Overnight 7729.00 + 14.00 0.18% S&P ASX 200 7712.50 + 8.30 0.11% S&a...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticleMomentum trading involves taking advantage of, and making profits from, upward trends in a stock. It...
Read ArticlePredictive diagnostics company Proteomics International Laboratories (ASX:PIQ) has successfu...
Read ArticleProteomics International Laboratories will continue important research and development for its diagn...
Read ArticleProteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has been awarded a Europea...
Read ArticleProteomics International Laboratories (ASX:PIQ) subsidiary, OxiDx, has secured a patent across 19 ma...
Read ArticleNeuren’s Daybue sales meet target Proteomics granted patent in Europe Nyrada’s brain injury drug...
Read ArticleExpert says buy US bonds now to lock in yields Viking Therapeutics doubled and Janux Therapeutic...
Read ArticleThe United States’ biggest government-funded healthcare provider Medicare has locked in a payment ra...
Read ArticleAlterity Therapeutics gets firm commitments for $4.8 million in capital raise Mesoblast partners wi...
Read ArticleProteomics International Laboratories’ share price has hit a seven-month high after a United States...
Read ArticlePIQ came out of trading suspension and surged 13pc PIQ says the US has set a national reimbursement...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, produced in a tearing rush because it’s the Friday befo...
Read ArticleASX health sector falls in line with broader markets as macroeconomic factors continue to create un...
Read Article2023 a case of “haves and have nots” for ASX biotech sector as companies with good catalysts lead t...
Read ArticleASX 200 ends sharply lower on Monday, down 0.67% All Sectors close in the red, with InfoTech taki...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleASX health sector fall in line with broader markets as macroeconomic factors create uncertainty Cli...
Read ArticleProteomics International (PIQ) is preparing to present its latest results from the company’s novel b...
Read ArticleProteomics International Laboratories has revealed new results showing that refinement of its simple...
Read ArticleFutures indicate the ASX is poised to open lower this morning as Wall Street grapples with the reper...
Read ArticleASX to open flat after a mixed session on Wall Street Semiconductor stocks slumped in US and Europe...
Read ArticleProteomics International Laboratories has been granted a breakthrough patent in Japan for its finger...
Read ArticleGenetic Signatures jumps on FDA 510(k) application Allegra says FDA has questions related to its 51...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ABB)...
Read ArticleProteomics International Laboratories has seen its cash receipts from clients increase by 5.8 per ce...
Read ArticleTrailblazing medtech Proteomics International Laboratories has been chosen to put its oesophageal ca...
Read ArticleEBR announces positive results of its pivotal SOLVE-CRT trial at Heart Rhythm 2023 in US EBR latest...
Read ArticleASX health stocks rise in the past five days outperforming broader markets Avita Medical product sa...
Read ArticleProteomics International Laboratories has secured a key partner for the looming roll-out of its Prom...
Read ArticleProteomics International (PIQ) signs an exclusive licence agreement with Sonic Healthcare USA to com...
Read ArticleThe ASX 200 benchmark has posted a solid slab of gains, up 0.78% for the day Energy and Materials h...
Read ArticleASX health stocks fall 0.8% in the past five days in line with broader markets following latest rat...
Read ArticleProteomics International Laboratories has strengthened its fight against kidney disease with the ide...
Read ArticleDiabetes drug Canagliflozin lowers Proteomics’ PromarkerD diabetic prediction scores Artrya says Q-...
Read ArticleThe ASX will open lower this morning after a 1% fall on Wall Street US regional bank stocks tumbled...
Read ArticleASX-listed Proteomics International Laboratories has beefed up its clinical advisory board ahead of...
Read ArticleProteomics International Laboratories’ plans for the global launch of its PromarkerD test for predic...
Read ArticleProteomics is confident of finalising a deal with Sonic Healthcare to use its PromarkerD test in it...
Read ArticleASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% af...
Read ArticleBenchmark set to finish close to flat as Energy stocks slump again Goldies are surging again, with...
Read ArticleProteomics International Laboratories says it has developed a simple new blood test to identify up t...
Read ArticleASX health stocks fall 1.5% in the past five days, broader markets fall on global banking concerns...
Read ArticleProteomics International Laboratories (ASX:PIQ) has announced that it will resubmit its appl...
Read ArticleASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a stat...
Read ArticleTony Locantro, Alto Capital BUY RECOMMENDATIONS Proteomics International Laboratories (PIQ) The comp...
Read ArticleProteomics International Laboratories (PIQ) extends its exclusive distribution agreement for Promark...
Read ArticleASX health stocks rise 4.6% this week with positive signs of being back in favour Volpara soars aft...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleASX health stocks rise 0.8% this week as smaller names in sector show signs of being back in favour...
Read ArticleThe ASX Health sector has fallen ~1.5% in its first trading week of 2023 Mach7 has surged after la...
Read ArticleAn exclusivity deal for use of Proteomics International Laboratories’ early diabetic kidney disease...
Read ArticleAussie shares set to extend gains on Thursday Wall Street pared gains after Fed minutes release Chi...
Read ArticleProteomics International Laboratories has hit another major milestone with its patented PromarkerD t...
Read ArticleMach7 signs up biggest client in its history Proteomics gets major regulatory approval in the US ...
Read ArticleProteomics International Laboratories (PIQ) receives reimbursement code approval from the American M...
Read ArticleProteomics International Laboratories’ PromarkerD technology is a step closer to a recommendation fo...
Read ArticleThe ASX is set to track Wall Street higher today US inflation shows signs of slowing down SBF charg...
Read ArticleASX Health sector has ended its upward trend falling 0.7% in the past five days in line with broade...
Read ArticleASX-listed Proteomics International Laboratories has received patent protection for its PromarkerD d...
Read ArticleProteomics International Laboratories (PIQ) secures a patent in Hong Kong for its diabetic kidney te...
Read ArticleCynata gets Notice of Allowance from US Patent Office Proteomics secures patent in Hong Kong Ramsay...
Read ArticleThe ASX is set to rally on Friday Wall St had its best one-day move since April 2020 US CPI rose le...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read ArticleASX-listed Proteomics International Laboratories will increase the capability of its WA Proteomics F...
Read ArticleFitbit has launched a new Device Connect service to give doctors your data Wellnex Life has raised...
Read ArticleProteomics International Laboratories’ (PIQ) first diagnostic test for oesophageal cancer has shown...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleHighlights The ASX 200 benchmark index closed lower today (29 August), losing 138.60 points or 1...
Read ArticleProteomics International Laboratories (PIQ) launches an independent business to commercialise techn...
Read ArticleProteomics International (PIQ) receives firm commitments to raise $8 million to advance marketing,...
Read ArticleRecent cap raising suggests biotechs may finally be making a comeback Mesblast annnounced a US$45m...
Read ArticleASX 200 and small caps rise circa 1% Regional markets jump on strong leads, US inflation data Ragus...
Read ArticleProteomics (PIQ) places its shares in a trading halt pending the release of a capital raising annou...
Read ArticleHighlights The ASX 200 benchmark index closed up today, gaining 0.13% to end at 7,029.80 points....
Read ArticleHighlights The ASX 200 benchmark index closed up today, gaining 0.13% to end at 7,029.80 points....
Read ArticleProteomics International Laboratories (PIQ) signs a binding letter of intent to introduce Promarker...
Read ArticleThe ASX 200 is pretty flat, small caps up circa 0.5% Materials and energy dragging locally Alibaba...
Read ArticleProteomics International Laboratories’ (PIQ) PromarkerD test has been ranked by physicians above cu...
Read ArticleProteomics International Laboratories (ASX:PIQ) has announced that a study demonstrating the...
Read ArticleThe ASX is poised to open Monday 0.70% higher Wall Street had its best month in July since November...
Read ArticleAsk A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insig...
Read ArticleAsk A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insig...
Read ArticleThe ASX is set to open slightly lower on Monday US social media stocks tumbled on Friday, with Snap...
Read ArticleProteomics International’s (PIQ) European patent protection for its PromarkerD predictive test has...
Read ArticleThe prospect of a simple blood test rather than an invasive surgical procedure to detect a painful g...
Read ArticleProteomics International Laboratories (PIQ) reports an initial positive diagnostic readout of its e...
Read ArticleProteomics International Laboratories (PIQ) secures a worldwide licence for oesophageal cancer biom...
Read ArticleResApp’s independent study of cough app falls short Recce Pharma completes Cohort 6 dosage in Phase...
Read ArticleASX is set open higher today with Wall Street on holidays overnight European stocks rallied RBA gov...
Read ArticleProteomics International Laboratories has passed a milestone in its drive to commercialise its Proma...
Read ArticleProteomics has completed a manufacturing technology transfer of its PromarkerD test Genetic Technol...
Read ArticleProteomics International Laboratories (PIQ) has produced a pilot batch of PromarkerD test component...
Read ArticleA new study shows Proteomics International Laboratories’ proven diagnostic test for diabetic kidney...
Read ArticleMedical technology company Proteomics International Laboratories has taken another step on its 10-ye...
Read ArticleRace Oncology is set to commence Phase 1 study of Zantrene after being given governance approval Rh...
Read ArticleProteomics International (PIQ) is awarded over $400,000 in funding to manufacture its predictive di...
Read ArticleProteomics International establishes world class Clinical Advisory Board promarkerd.com/clinic...
Read ArticleChimeric wants to accelerate its clinical trial readiness via a deal with WuXi Recce advances to hi...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe ASX 200 Health Index (XHJ) and the benchmark ASX 200 are trading flat today. Proteomics advances...
Read ArticleProteomics International Laboratories (PIQ) completes a study targeting oesophageal adenocarcinoma...
Read ArticleASX to fall as Meta crash derails Tech rebound Local shares are expected to open lower this morning...
Read ArticleThe ASX 200 Health Index (XHJ) has dropped by almost 5% at the time of writing, compared to the broa...
Read ArticleWall Street rallies on Fed decision US stocks rallied strongly overnight, as investors digested the...
Read ArticleProteomics International Laboratories (PIQ) sees its cash reserves strengthened by a $1.2 million r...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleWorld’s first predictive diagnostic test for diabetic kidney disease to be sold in Great Brita...
Read ArticleProteomics International Laboratories (PIQ) signs a deal with medical diagnostics company Apacor to...
Read ArticleStudy shows PromarkerD is significantly better than current standard of care tests eGFR and AC...
Read ArticleWall Street sets record highs for fifth consecutive day US stocks closed their fifth consecutive day...
Read ArticleProteomics International Laboratories (PIQ) says study results show PromarkerD is superior to the c...
Read ArticleProteomics International Laboratories (PIQ) has been awarded a $100,000 voucher to manufacture clin...
Read ArticleIt’s been a busy morning for the ASX Healthcare sector, with plenty of positive announcements for in...
Read ArticleBRISBANE, Australia, Aug. 12, 2021 /PRNewswire/ — Treatment with diabetes drug canagliflozin lowers...
Read ArticleSummary The Australian benchmark index, ASX200, added 4 points to close at fresh closing high o...
Read ArticleProteomics International Laboratories (ASX:PIQ) has announced it has contracted French immun...
Read ArticleSummary REA Group (ASX:REA) completes transaction with PropertyGuru BNK Banking (ASX:BBC) annou...
Read ArticleSummary Benchmark index, the ASX 200, hit a record high of 7,509.2 this morning. The market was...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAustralian shares have extended gains for the second day in a row, rising by 0.91% despite more COVI...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleProteomics International Laboratories says a retrospective study has found diabetes patients using t...
Read ArticleThe Proteomics International Laboratories Ltd (ASX: PIQ) share price has jumped firmly into the gre...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleThe Proteomics International Laboratories Ltd (ASX: PIQ) share price won’t be going anywhere today....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAustralian shares appeared to shrug off the latest COVID-19 lockdowns for much of the day, but ultim...
Read ArticleAround 1 million residents of some inner-Sydney suburbs are to stay at home until next Friday, after...
Read ArticleProteomics International Laboratories says independent research on its “ground-breaking” PromarkerD...
Read ArticleWall Street climbs on Biden stimulus All three major US benchmarks rose on Thursday, as President Bi...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleProteomics International Laboratories (ASX:PIQ) has announced the expansion of its executive...
Read ArticleAsk a Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how...
Read ArticleSummary Oncology firm Telix Pharmaceuticals has entered into an exclusive commercial distributio...
Read ArticleMedical technology group, Proteomics International Laboratories has picked up an analytical services...
Read ArticleA series of ASX announcements has attracted investors to the biotech sector today, lifting the share...
Read ArticleSummary Telix Pharmaceuticals signs distribution agreement with Germany based company Proteomic...
Read ArticleUS and European stock markets down to start the week All major indices in US and Europe were down on...
Read ArticleMedical technology group, Proteomics International Laboratories says an economic health benefit stud...
Read ArticleSell-off on Wall Street after inflation rose to highest since 2009 All major indices in US tumbled a...
Read ArticleAfter flying 5% higher this morning, it was downhill all the way for the Proteomics International L...
Read ArticleProteomics International Laboratories has received an ISO 13485 certification, which it describes as...
Read ArticleASX-listed medical technology company, Proteomics International Laboratories’ coffers have been furt...
Read ArticleASX-listed medical technology company, Proteomics International Laboratories, has locked away $6m in...
Read ArticleProteomics International Laboratories (ASX:PIQ) has announced it has signed a distribution l...
Read ArticleASX-listed medical technology company, Proteomics International Laboratories, has entered into an ag...
Read ArticleAustralian company Proteomics International (ASX:PIQ) says it has secured patents for Promar...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleMedical technology company Proteomics International Laboratories (ASX: PIQ) announced that a global...
Read ArticleProteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, has secure...
Read ArticleProteomics International Laboratories (PIQ) has secured CE Mark registration for the PromarkerD Hub...
Read ArticleOrthocell (ASX:OCC) has found a new use for its CelGro tech – anterior cruciate ligament (ACL) injur...
Read ArticleProteomics International Laboratories (ASX: PIQ) has embarked on a European commercialisation campai...
Read ArticleBiotech company Mesoblast (ASX:MSB) has entered into a strategic partnership to develop and commerci...
Read ArticleConcurrently, TGA regulatory approval granted for PromarkerD software as an in vitro diagnostic for...
Read ArticleAustralian healthcare industry challenges include an ageing population, increased rate of chronic di...
Read ArticleAustralia’s cannabis industry continues to edge forward under the watchful eye of regulators. For no...
Read ArticlePerth-based Proteomics International Laboratories (ASX:PIQ) says it has been invited to feat...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
